NYSE Suspends Trading and Begins Delisting Crown PropTech’s Warrants

Crown PropTech

The New York Stock Exchange has suspended trading and begun listing the warrants of Crown PropTech Acquisitions. Trading in the SPAC’s shares and units will continue.

NYSE regulators in a statment said the decision was based on “abnormally low” price levels for the warrants.

The SPAC has a right to a review.

Crown PropTech suffered a setback in August when merger partner Brivo abandoned the deal, a move the SPAC at the time vowed to oppose and “vigorously pursue its remedies.” In July, Golub Capital terminated its $68 million PIPE in the Brivo deal because it was not completed by the deadline. Read more.

Total
0
Shares
Related Posts
Read More

Sanaby Health I to Dissolve

The SPAC raised $172.5 million in an October 2021 IPO with plans to identify opportunities in the healthcare industry, with a focus on digital health, life science tools and services, and innovative therapeutics.